Handok

Handok company information, Employees & Contact Information

Explore related pages

Related company profiles:

HANDOK is a leading innovation-driven pharmaceutical/health-care company in Korea, develops, manufactures and distributes healthcare solutions to improve the health and quality of human life. It was founded in 1954 and has been dedicated to developing and providing innovative pharmaceutical products (Prescription drugs & OTC drugs), medical devices, and in vitro diagnostics. Handok grew with its joint venture partner Hoechst/Aventis/Sanofi from 1964 to 2012. In several areas Handok has also established strategic collaborations with multiple multinational pharmaceutical companies. Handok ended its joint venture relationship with Sanofi in 2012. In 2013, Handok changed its company name from Handok Pharmaceutical Co., Ltd to Handok Inc. and declared its vision to become, “The Health Innovator” as Korea’s leading global healthcare company. “모두의 더 건강한 삶을 위해 대한민국을 대표하는 The Health Innovator가 되겠습니다” 한독은 1954년 창업 이래 세계 유수 제약사들과 협력관계를 맺으며 변화와 성장을 거듭해 왔습니다. 1964년 독일 훽스트와의 합작을 시작으로 합작 파트너가 아벤티스, 사노피로 바뀌는 48년간, 선진 제약기술과 우수의약품을 한국에 도입하며 대한민국 제약산업의 선진화를 이끌었습니다. 1992년 본사 사옥을 강남 테헤란로로 이전하고 충북 음성에 1995년 국내 최고의 GMP 생산시설을 준공한 한독은 일찍이 선진 경영기법과 마케팅 전략을 도입하고 글로벌스탠다드 시스템(Global Standard System)을 갖춰왔습니다. 2012년 10월 독자기업이 되었으며, 2013년 한독약품에서 한독으로 사명을 변경했습니다. 한독은 대한민국을 대표하는 글로벌 토탈헬스케어 기업으로서 The Health Innovator가 되겠다는 비전을 선포하고 바이오 벤처 ‘제넥신’ 지분투자, 세계 1위 제네릭 기업인 이스라엘 테바와 합작회사 ‘한독테바’ 설립, 케토톱으로 유명한 ‘태평양제약 제약사업부문’ 인수, 치료 의료기기 벤처 ‘칼로스메디칼’ 설립, 일본 기능성 원료 회사 ‘테라밸류즈’ 인수 등 미래 성장 동력을 확보하고 글로벌 진출을 확대하기 위한 혁신적인 도전을 이어오고 있습니다. 현재 한독은 전문의약품, 일반의약품, 진단시약과 의료기기, 건강기능식품, 특수의료용도 식품 등 다양한 헬스케어 제품과 서비스를 제공하고 있습니다. 또, 한독은 모두의 더 건강한 삶을 위해 오픈 이노베이션 전략으로 경쟁력을 갖춘 연구개발을 펼쳐 나가고 있으며 혁신 바이오의약품, 표적항암제, 의료기기 개발에 집중하고 있습니다. 2022년 한독은 서울시 강서구 마곡지구에 ‘한독 퓨쳐 콤플렉스’를 준공해 분리되어 있었던 제품개발연구소와 신약개발연구소를 한독 퓨쳐콤플렉스로 통합 이전하며 R&D 역량을 강화했습니다. 더불어 초기 단계의 바이오스타트업을 발굴하고 육성하는 "이노큐브"를 통해 신약개발을 위한 이노베이션플랫폼을 확장했습니다. 한독은 남들보다 한발 앞서, 높은 기준의 윤리경영과 투명경영을 실천하고 있으며, 직원이 행복해야 기업이 함께 성장한다는 믿음으로 직원 스스로 즐겁게 일할 수 있는 기업문화를 만들어 오고 있습니다.

Company Details

Employees
368
Founded
-
Address
서울시 강남구 테헤란로 132, 한독빌딩,korea, Republic Of
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
서울특별시
Looking for a particular Handok employee's phone or email?

Handok Questions

News

Handok launches new healthcare subsidiary to target global curcumin market - koreabiomed.com

Handok launches new healthcare subsidiary to target global curcumin market koreabiomed.com

HANDOK launches HANDOK Healthcare to enhance health food market presence - CHOSUNBIZ - Chosun Biz

HANDOK launches HANDOK Healthcare to enhance health food market presence - CHOSUNBIZ Chosun Biz

Handok advances ABL Bio-partnered cancer drugs after securing Korean rights - koreabiomed.com

Handok advances ABL Bio-partnered cancer drugs after securing Korean rights koreabiomed.com

Hello, MK Pharmacy readers! Now, the weather is quite warm enough to find people walking in the midd.. - 매일경제

Hello, MK Pharmacy readers! Now, the weather is quite warm enough to find people walking in the midd.. 매일경제

Handok signs agreement with Microsoft Korea for digital transformation - The Korea Economic Daily Global Edition

Handok signs agreement with Microsoft Korea for digital transformation The Korea Economic Daily Global Edition

Handok-Genexine’s long-acting growth hormone gets orphan drug status in Korea - The Korea Herald

Handok-Genexine’s long-acting growth hormone gets orphan drug status in Korea The Korea Herald

Finally, the long-awaited Lunar New Year holiday has begun. You'll have a long holiday until the 6th.. - 매일경제

Finally, the long-awaited Lunar New Year holiday has begun. You'll have a long holiday until the 6th.. 매일경제

Handok to Export 10 Bil. Won Worth of Ketotop to Algerian Company - Businesskorea

Handok to Export 10 Bil. Won Worth of Ketotop to Algerian Company Businesskorea

Handok gets Biocon's obesity drug exclusive distribution in S.Korea - The Korea Economic Daily Global Edition

Handok gets Biocon's obesity drug exclusive distribution in S.Korea The Korea Economic Daily Global Edition

Handok’s 2023 turnover to drop sharply as AZ retrieves sales rights - koreabiomed.com

Handok’s 2023 turnover to drop sharply as AZ retrieves sales rights koreabiomed.com

Handok will exclusively sell and distribute Biocon’s liraglutide-based obesity treatment in Korea - koreabiomed.com

Handok will exclusively sell and distribute Biocon’s liraglutide-based obesity treatment in Korea koreabiomed.com

Handok paves the way for a smooth introduction of its new cancer drug - koreabiomed.com

Handok paves the way for a smooth introduction of its new cancer drug koreabiomed.com

Handok's AML drug Vyxeos moves closer to reimbursement - koreabiomed.com

Handok's AML drug Vyxeos moves closer to reimbursement koreabiomed.com

Handok's CGM Barojen Fit linked to Samsung's health platform - koreabiomed.com

Handok's CGM Barojen Fit linked to Samsung's health platform koreabiomed.com

Sanofi's epilepsy drug distributed by Handok designated as essential drug in Korea - koreabiomed.com

Sanofi's epilepsy drug distributed by Handok designated as essential drug in Korea koreabiomed.com

‘Our next target is anticancer drug,’ Handok chairman says - koreabiomed.com

‘Our next target is anticancer drug,’ Handok chairman says koreabiomed.com

Sobi-Handok joint venture raises expectations about Kineret launch in Korea - koreabiomed.com

Sobi-Handok joint venture raises expectations about Kineret launch in Korea koreabiomed.com

Teva-Handok wins approval for anti-asthma injection - koreabiomed.com

Teva-Handok wins approval for anti-asthma injection koreabiomed.com

Handok’s Soliris expands indication to NMOSD - koreabiomed.com

Handok’s Soliris expands indication to NMOSD koreabiomed.com

Handok aims to dominate patch market with new production plant - koreabiomed.com

Handok aims to dominate patch market with new production plant koreabiomed.com

Handok’s medicine for childhood hypophosphatasia gets insurance benefits - koreabiomed.com

Handok’s medicine for childhood hypophosphatasia gets insurance benefits koreabiomed.com

[News Focus] Handok sidesteps regulation to promote anti-Alzheimer drink - koreabiomed.com

[News Focus] Handok sidesteps regulation to promote anti-Alzheimer drink koreabiomed.com

Teva Handok gets reimbursement for narcolepsy drug - koreabiomed.com

Teva Handok gets reimbursement for narcolepsy drug koreabiomed.com

Rezolute Completes $45 Million Investment Round with Full Exercise of $20 Million Option - Koreabizwire

Rezolute Completes $45 Million Investment Round with Full Exercise of $20 Million Option Koreabizwire

Handok inks W10b deal to export Ketotop - theinvestor.co.kr

Handok inks W10b deal to export Ketotop theinvestor.co.kr

AZ Leads PNH Market as Samsung, Handok, Novartis Join Competition - 히트뉴스

AZ Leads PNH Market as Samsung, Handok, Novartis Join Competition 히트뉴스

Top Handok Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant